Virtus LifeSci Biotech Products ETF (BBP)
| Assets | $17.17M |
| Expense Ratio | 0.79% |
| PE Ratio | n/a |
| Shares Out | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +18.53% |
| Volume | 509 |
| Open | 58.17 |
| Previous Close | 58.58 |
| Day's Range | 58.08 - 58.17 |
| 52-Week Low | 45.00 |
| 52-Week High | 59.10 |
| Beta | n/a |
| Holdings | 55 |
| Inception Date | Dec 17, 2014 |
About BBP
Fund Home PageThe Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.
Top 10 Holdings
21.32% of assets| Name | Symbol | Weight |
|---|---|---|
| BridgeBio Pharma, Inc. | BBIO | 2.26% |
| Apellis Pharmaceuticals, Inc. | APLS | 2.23% |
| Moderna, Inc. | MRNA | 2.16% |
| Amicus Therapeutics, Inc. | FOLD | 2.14% |
| Rhythm Pharmaceuticals, Inc. | RYTM | 2.13% |
| Axsome Therapeutics, Inc. | AXSM | 2.11% |
| ACADIA Pharmaceuticals Inc. | ACAD | 2.09% |
| Intra-Cellular Therapies, Inc. | ITCI | 2.08% |
| Lexicon Pharmaceuticals, Inc. | LXRX | 2.07% |
| ADMA Biologics, Inc. | ADMA | 2.05% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 20, 2017 | $0.0723 | Dec 27, 2017 |
| Dec 21, 2015 | $0.39725 | Dec 29, 2015 |
News
Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal
Biotechnology sector-related exchange traded funds continued to rally Friday on reports that Pfizer Inc. (NYSE: PFE) is looking to acquire Global Blood Therapeutics (NasdaqGS: GBT). On Friday, the Vir...
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics
Global Blood Therapeutics (NasdaqGS: GBT) shares climbed Thursday, lifting biotechnology sector-related exchange traded funds, on speculation of takeover bids for the small drug developer. On Thursday...
Biotech ETFs Are Making a Comeback
Biotechnology stocks and sector-related exchange traded funds have been gaining momentum as investors return to this downtrodden segment of the market. Over the past month, the Virtus LifeSci Biotech ...
Late-stage biotech ETFs rally Monday on virus treatment hopes
Late-stage biotech exchange-traded funds were among the day's biggest gainers Monday as investors pinned their hopes on medical responses to the novel coronavirus. The ALPS Medical Breakthroughs ETF ...
ACADIA Pharmaceuticals Help Lift Biotech ETFs
While the rest of the biotechnology sector remained depressed along with the broader markets, related exchange traded funds found strength from an unexpected surge in ACADIA Pharmaceuticals (NasdaqGS:...